Correlation of Immunohistochemistry Expression of Matrix Metalloproteinase-9 with Peritumoral Budding and Molecular Subtype in Invasive Breast Carcinoma of No Special Type
Authors:
Open Access
- 10 April 2025
- journal article
- Published by Indonesian Association of Pathologists in Majalah Patologi Indonesia
- Vol. 34 (1)
Abstract
Background Breast cancer ranks first most often in the world and is a malignant cancer that often occurs in women. Matrix metalloproteinase-9 (MMP-9) has been the focus of attention in several previous studies in the field of breast cancer. MMP-9 plays a role in the degradation of the extracellular matrix. High expression of MMP-9 is associated with tumor aggressiveness, metastatic potential and poor prognosis. The presence of tumor budding and molecular subtypes also indicates tumor aggressiveness, one of which is the potential for metastasis through extracellular matrix degradation. The aim of this study was to analyze the association of MMP-9 mmunohistochemistry expression with peritumoral tumor budding and molecular subtypes in IBC-NST. Methods This study is an analytic study with a cross sectional approach on 41 samples of paraffin block cases of IBC-NST which had been diagnosed histopathologically and then performed with MMP-9 mmunohistochemistry staining. The correlation between the immunohistochemical expression of MMP-9 with peritumoral tumor buds and molecular subtypes in IBC-NST was tested statistically using Somers'd test and Eta test. Results There was a significant relationship between the immunohistochemistry expression of MMP-9 with peritumoral tumor budding and molecular subtypes. Conclusion Reporting the results of MMP-9 expression on IBC-NST can be one of the prognostic criteria that can be applied in routine examinations. However, the relationship with prognosis cannot be concluded from this study because it is not associated with survival rateKeywords
This publication has 24 references indexed in Scilit:
- A Retrospective Study of Association of Tumor Budding, Tumor Microenvironment, and Clinicopathological Characteristics of Invasive Breast CarcinomaJournal of Laboratory Physicians, 2022
- Tumour budding is a novel marker in breast cancer: the clinical application and future prospectsAnnals of Medicine, 2022
- Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parametersAnnals of Diagnostic Pathology, 2021
- Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special typeScientific Reports, 2021
- Tumour budding in solid cancersNature Reviews Clinical Oncology, 2020
- Lifestyle Patterns and Survival Following Breast Cancer in the Carolina Breast Cancer StudyEpidemiology, 2019
- Molecular Subtypes and Local-Regional Control of Breast CancerSurgical Oncology Clinics of North America, 2018
- Matrix metalloproteinases (MMPs) in oral diseasesOral Diseases, 2004
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Molecular portraits of human breast tumoursNature, 2000